Median Technologies (ALMDT) | Stock Overview & Key Data
Median Technologies S.A. | Small-cap | Healthcare
Median Technologies S.A. | Small-cap | Healthcare
Median Technologies Performance Comparison
Stock Range
Today's Range
Low: €2.32
High: €2.58
on August 22, 2025
52 Week Range
Low: €1.19
High: €7.47
on June 18, 2025
on August 22, 2024
All-Time High: €18.32 on October 18, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€91.7M
EPS
-1.37
P/E Ratio (TTM)
-1.84
Forward P/E
-2.41
P/B Ratio
N/A
PEG Ratio
N/A
Div. Yield
N/A
ROE
74.31%
Beta
0.651
Debt to Equity
-0.98
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-76.84%
Profit Margin
-109.93%
Returns and Earnings
Return on Assets (TTM)
-46.71%
Return on Equity (TTM)
74.31%
EBITDA
€-22.2M
Net Income (TTM)
€-25.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€1.25
Quarterly Revenue Growth (YoY)
5.60%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Median Technologies ALMDT | 91.70M Small-cap | -12.31% | 14.08% | 5.38% | -10.31% | -44.58% | -66.28% | -77.83% | -63.62% |
| Guerbet S.A GBT | 293.77M Mid-cap | -1.34% | 2.80% | 9.70% | -18.03% | -17.72% | -34.38% | 12.16% | -25.38% |
| Eurobio Scientific ALERS | 251.86M Mid-cap | -0.39% | 1.00% | 0.00% | -0.39% | 0.00% | 2.43% | 32.11% | 120.00% |
| Affluent Medical AFME | 60.00M Small-cap | 14.58% | 32.00% | 18.71% | 23.13% | 18.71% | -15.38% | -42.71% | -79.25% |
| Novacyt S.A ALNOV | 34.83M Small-cap | -2.04% | 2.13% | 2.13% | -18.64% | -21.31% | -58.97% | -57.14% | -85.88% |
| Theraclion S.A ALTHE | 31.40M Small-cap | 9.23% | 86.84% | 153.57% | 273.68% | 97.22% | 136.67% | -36.61% | -44.09% |
Ownership & Short Interest
Insider Ownership
14.37%
Institutional Ownership
10.22%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
428K
Average 90-Day Volume
344K
Median Technologies Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Median Technologies would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALMDT's 52-week high and low?
- In the last 52 weeks, Median Technologies reached a high of €7.47 (on August 22, 2024) and a low of €1.19 (on June 18, 2025).
- What is the market cap and P/E ratio for ALMDT?
- Curious about Median Technologies's size and valuation? Its market capitalization stands at 91.70M. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.84, and the forward P/E (looking ahead) is -2.41.
- Does ALMDT pay dividends? If so, what's the yield?
- As for dividends, Median Technologies isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Median Technologies's main competitors or similar companies to consider before investing?
When looking at Median Technologies, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Guerbet S.A
GBT293.77M Healthcare Medical Devices -34.38% 12.16% Eurobio Scientific
ALERS251.86M Healthcare Medical Devices 2.43% 32.11% Affluent Medical
AFME60.00M Healthcare Medical Devices -15.38% -42.71% Novacyt S.A
ALNOV34.83M Healthcare Medical Devices -58.97% -57.14% Theraclion S.A
ALTHE31.40M Healthcare Medical Devices 136.67% -36.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Median Technologies S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Median Technologies's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 74.31%, the Debt to Equity ratio from the most recent quarter is -0.98, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALMDT?
- Looking at Median Technologies's growth, its revenue over the trailing twelve months (TTM) was €23M. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.60%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALMDT stock is held by insiders and institutions?
- Wondering who owns Median Technologies stock? Company insiders (like executives and directors) hold about 14.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 10.22%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.